 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References Relevant publications listed by the last name of
the first author.
Vaayssier M,
Favatier F, Pinot F, Bachelet M and Polla BS (1998) Tobacco smoke induces
coordinate activation of NSF and inhibition of NFkB in human monocytes:
effects on TNFa release. Biochemical and Biophysical Research Communications
252 249-256 Vafeiadou K, Vauzour D and Spencer JP (2007) Neuroinflammation and its modulation by flavonoids. Endocrine, Metabolic & Immune Disorder Drug Targets 7 211-224 Vaillancourt F, Morquette B, Shi Q, Fahmi H, Lavigne P, Di Battista JA, Fernandes JC and Benderdour M (2007) Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase by 4-hydroxynonenal in human osteoarthritic chondrocytes through ATF-2/CREB-1 transactivation and concomitant inhibition of NF-kB signaling cascade. Journal of Cellular Biochemistry 100 1217-1231 Vainer GW, Pikarsky E and Ben-Neriah Y (2008) Contradictory functions of NF-kB in liver physiology and cancer. Cancer Letters in press Vaira S, Alhawagri M, Anwisye I, Kitaura H, Faccio R and Novack DV (2008) RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. Journal of Clinical Investigation 118 2088-2097 Vaira S, Johnson T, Hirbe AC, Alhawagri M, Anwisye I, Sammut B, O'Neal J, Zou W, Weilbaecher KN, Faccio R and Novack DV (2008) RelB is the NF-kB subunit downstream of NIK responsible for osteoclast differentiation. Proceedings of the National Academy of Sciences USA 105 3897-3902 Vaisman N, Haenen GR, Zaruk Y, Verduyn C, Bindels JG, Verlaan S and Meijer EP (2006) Enteral feeding enriched with carotenoids normalizes the carotenoid status and reduces oxidative stress in long-term enterally fed patients. Clinical Nutrition 25 897-905 Vaititis GM and Wagner Jr DH (2008) High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunity. PLos ONE 3 e2076
Vakkila J, Demarco RA and Lotze MT (2004) Imaging analysis of STAT1 and NF-kB
translocation in dendritic cells at the single cell level. Journal of
Immunological Methods 294 123-134
Valacchi G, Pagnin E, Phung A, Nardini M, Schock BC, Cross CE and Van Der
Vliet A (2005) Inhibition of NFkB activation and IL-8 expression in human
bronchial epithelial cells by acrolein. Antioxidant and Redox Signaling 7 25-31 Valacchi
G, Pagnin E, Corbacho AM, Olano E, Davis PA, Packer L and Cross CE (2004) In
vivo ozone exposure induces antioxidant/stress-related responses in murine
lung and skin. Free Radical Biology and Medicine 36 673-681 Valdes JA, Hidalgo J, Galaz JL, Puentes N, Silva J, Jaimovich E and Carrasco MA (2007) NF-kB activation by depolarization of skeletal muscle cells depends on ryanodine and IP3 receptor-mediated calcium signals. American Journal of Physiology: Cell Physiology 292 C1960-C1970 Valdez KE and Turzillo AM (2005) Regulation of nuclear factor-kB (NF-kB) activity and apoptosis by estradiol in bovine granulosa cells. Molecular and Cellular Endocrinology 243 66-73 Valdiva C, Marquez N, Eriksson J, Vilaseca A, Munoz E and Sterner O (2008) Bioactive alkenylphenols from Piper obliquum. Biorganic Medicinal Chemistry 16 4120-4126 Vale T, Ngo
TT, White MA and Lipsky PE (2001) Raf-induced transformation requires an
interleukin 1 autocrine loop. Cancer Research 61 602-607 Valen G (2004) NFkB in myocardial inflammation. Cardiovascular Journal of South Africa 15 S6 Valen G,
Paulsson G and Vaage J (2001) Induction of inflammatory mediators during
reperfusion of the human heart. Annals of Thoracic Surgery 71 226-232 Valen
G, Yan ZQ and Hansson GK (2001) Nuclear factor kB and the heart. Journal of
the American College of Cardiology 38 307-314 Valencia C, Cornejo P, Romanque P, Tapia G, Varela P, Videla LA and Fernandez
V (2004) Effects of acute lindane intoxication and thyroid hormone
administration in relation to nuclear factor-kB activation, tumor necrosis
factor-a expression, and Kupffer cell function in the rat. Toxicology Letters
148 21-28 Valera FC, Queiroz R, Scrideli C, Tone LG and Anselmo-Lima WT (2008) Expression of transcription factors NF-kB and AP-1 in nasal polyposis. Clinical and Experimental Allergy 38 579-585 Valeri CR, Ragno G and Veech RL (2006) Effects of the resuscitation fluid and
the hemoglobin based oxygen carrier (HBOC) excipient on the toxicity of the
HBOC: Ringer's D,L-lactate, Ringer's L-lactate, and Ringer's ketone solutions. Valerio A, Boroni F, Benarese M, Sarnico L, Ghisi V, Bresciani LG, Ferrario M, Borsani G, Spano P and PIzzi M (2006) NF-kB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production. European Journal of Neuroscience 23 1711-1720 Valerio LG and Gonzales GF (2005) Toxicological aspects of the South American herbs Cat's Claw (Uncaria tomentosa) and Maca (Lepidium meyenii): a critical synopsis. Toxicology Reviews 24 11-35 Valero R, Baron ML, Guerin S, Beliard S, Lelouard H, Kahn-Perles B, Vialettes B, Nguyen C, Imbert J and Naquet P (2002) A defective NF-kB/RelB pathway in autoimmune-prone New Zealand black mice is associated with inefficient expansion of thymocyte and dendritic cells. Journal of Immunology 169 185-192 Vales LD and Friedl EM (2002) Binding of C/EBP and RBP (CBF1) to overlapping sites regulates IL-6 gene expression. Journal of Biological Chemistry 277 42438-24446 Valko M, Morris H and Cronin MT (2005) Metals, toxicity and oxidative stress. Current Medicinal Chemistry 12 1161-1208 Valko M, Rhodes CJ, Moncol J, Izakovic M and Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-Biological Interactions 160 1-40 Vallabhapurapu S and
Karin M (2009) Regulation and function of NF-kB transcription factors in the
immune system. Annual Reviews of Immunology
27 693-733 Vallabhapurapu
S, Ryseck RP, Malewicz M, Weih DS and Weih F (2001) Inhibition of NF-kB in T
cells blocks lymphoproliferation and partially rescues autoimmune disease in
gld/gld mice. European Journal of Immunology 31 2612-2622 Vallon V, Wyatt AW, Klingel K, Huang DY, Hussain A, Berchtold S, Friedrich B, Grahammer F, Belaiba RS, Gorlach A, Wulff P, Daut J, Dalton ND, Ross Jr J, Flogel U, Schrader J, Osswald H, Kandolf R, Kuhl D and Lang F (2006) SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment. Journal of Molecular Medicine 84 396-404 Valnet-Rabier MB, Challier B, Thiebault S, Angonin R, Margueritte G, Mougin C, Kantelip B, Deconinck E, Cahn JY and Fest T (2005) c-Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome. British Journal of Haematology 128 767-773 Van Acker GJ, Weiss E, Steer ML and Perides G (2007) Cause-effect relationships between symogen activation and other early events in secretagogue-induced acute pancreatitis. American Journal of Physiology: Gastrointestinal and Liver Physiology 292 G1738-G1746 Van Antwerp
DJ and Verma IM (1996) Signal-induced degradation of IkBa: association with
NF-kB and the PEST sequence in IkBa are not required. Molecular and Cellular
Biology 16 6037-6045 Van Antwerp
DJ, Martin SJ, Kafri T, Green DR and Verma I (1996) Suppression of
TNF-a-induced apoptosis by NF-kB. Science 274 787-789 Van Antwerp
DJ, Martin SJ, Verma IM and Green DR (1998) Inhibition of TNF-induced
apoptosis by NF-kB. Trends in Cell Biology 8 107-111 van Asbeck
BS, Georgiou NA, van der Bruggen T, Oudshoorn M, Nottet HS and Marx JJ (2001)
Anti-HIV effect of iron chelators: different mechanisms involved. Journal of
Clinical Virology 20 141-147 van Aubel RA, Keestra AM, Krooshoop DJ, van Eden W and van Putten JP (2007) Ligand-induced differential cross-regulation of Toll-like receptors 2, 4 and 5 in intestinal epithelial cells. Molecular Immunology 44 3702-3714 Van
Bezooijen RL, Papapoulos SE and Lowik CW (2001) Effect of interleukin-17 on
nitric oxide production and osteoclastic bone resorption: is there dependency
on nuclear factor-kB and receptor activator of nuclear factor kB
(RANK)/RANK ligand signaling? Bone 28 378-386 Van De Stolpe A, Slycke AJ, Reinders MO, Zomer AW, Goodenough S, Behl C, Seasholtz AF and Van Der Saag PT (2004) Estrogen receptor (ER)-mediated transcriptional regulation of the human Corticotropin-Releasing Hormone-Binding Protein promoter: differential effects of ERa and ERb. Molecular Endocrinology 18 2908-2923 Van De Walle J, Romier B, Larondelle Y and Schneider YJ (2008) Influence of deoxynivalenol on NF-kB activation and IL-8 secretion in human intestinal Caco-2 cells. Toxicology Letters 177 205-214 Van De Woouwer M, Plaisance S, De Vriese A, Waelkens D, Collen D, Persson J, Daha MR and Conway EM (2006) The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis. Journal of Thrombosis and Haemostosis 4 1813-1824 Van Den Berg A, Kroesen BJ, Kooistra K, De Jong D, Briggs J, Blokzijl T,
Jacobs S, Kluiver J, Diepstra A, Maggio E and Poppema S (2003) High expression
of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma.
Genes Chromosomes and Cancer 37 20-28 van den Brandt J, Kwon SH, McPherson KG,
Petrovic S, Zettle A, Muller-Hermelink HK and Reichardt HM (2006) Unexpected
features of acute T lymphoblastic lymphomas in Notch1IC transgenic rats. van Den Brink GR, ten Kate FJ, Ponsioen CY, Rive MM, Tytgat
GN, van Deventer SJ and Peppelenbosch MP (2000) Expression and activation of
NF-kB in the antrum of the human stomach. Journal of Immunology 164 3353-3359 van den Tweel ER, Kavelaars A, Lombardi MS, Groenendaal F, May M, Heijnen CJ and van Bel F (2006) Selective inhibition of nuclear factor-kB activation after hypoxia/ischemia in neonatal rats is not neuroprotective. Pediatric Research 59 232-236 van der Crabben SN, Allick G, Ackermans MT, Endert E, Romijn JA and Sauerwein HP (2008) Prolonged fasting induces peripheral insulin resistance, which is not ameliorated by high-dose salicylate. Journal of Clinical Endocrinology and Metabolism 93 638-641 Van Der Hoeven JA, Moshage H, Schuurs T, Nijboer M, Van Schilfgaarde R and Ploeg RJ (2003) Brain death induces apoptosis in donor liver of the rat. Transplantation 76 1150-1154
Van Der Paardt M, Crusius JB, De Koning MH, Murillo LS, Van De Stadt RJ,
Dijkmans BA, Pena AS and Van Der Horst-Bruinsma IE (2003) CARD15 gene
mutations are not associated with ankylosing spondylitis. Genes and Immunity 4
77-78 Van Epps HL (2006) Finding NEMO mutations. Journal of Experimental Medicine 203 1620 van Erk MJ, Blom WA, van Ommen B and Hendriks HF (2006) High-protein and high-carbohydrate breakfasts differentially change the transcriptome of human blood cells. American Journal of Clinical Nutrition 84 1233-1241 van Etten E, Verlinden L, Giulietti A, Ramos-Lopez E, Branisteanu DD, Ferreira GB, Overbergh L, Verstuyf A, Bouillon R, Roep BO, Badenhoop K and Mathieu C (2007) The vitamin D receptor gene FokI polymorphism: Functional impact on the immune system. European Journal of Immunology 37 395-405
van Eyndhoven
WG, Gamper CJ, Cho E, Mackus WJ and Lederman S (1999) TRAF-3 mRNA
splice-deletion variants encode isoforms that induce NF-kappaB activation.
Molecular Immunology 36 647-658 Van Heel DA, McGovern DP and Jewell DP (2001) Crohn's disease: genetic susceptibility, bacteria, and innate immunity. Lancet 357 1902-1904 Van Heel DA, Udalova IA, De Silva AP, McGovern DP, Kinouchi Y, Hull J, Lench NJ, Cardon LR, Carey AH, Jewell DP and Kwiatkowski D (2002) Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-kB transcription factors. Human Molecular Genetics 11 1281-1289
Van Hogerlinden M, Auer G and Toftgard R (2002) Inhibition of Rel/Nuclear factor-kB signaling in skin results in defective DNA damage-induced cell cycle arrest and Ha-ras- and p53- independent tumor development. Oncogene 21 4969-4977 van
Hogerlinden M, Rozell BL, Ährlund-Richter L and Toftgård R (1999) Squamous
cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear
factor-kB signaling. Cancer Research 59 3299-3303 Van
Huffel S, Delaei F, Heyninck K, De Valck D and Beyaert R (2001)
Identification of a novel A20-binding inhibitor of nuclear factor-kB
activation termed ABIN-2. Journal of Biological Chemistry 276 30216-30223 Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL, van Dam P, Van Marck EA, Vermeulen PB and Dirix LY (2006) Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis. Cancer Research 66 5744-5756 Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL, van Dam P, Van Marck EA, Vermeulen PB and Dirix LY (2006) Nuclear factor-kB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kB DNA-binding. Clinical Cancer Research 12 3249-3256 Van Laere SJ, Van der Auwera I, Van den Eynden GG, van Dam P, Van Marck EA, Vermeulen PB and Dirix LY (2007) NF-kB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. British Journal of Cancer 97 659-669 van
Leeuwen HJ, van der Bruggen T, van Asbeck BS and Boereboom FT (2001) Effect
of corticosteroids on nuclear factor-kB activation and hemodynamics in
late septic shock. Critical Care Medicine 29 1074-1077 van Loo G, De Lorenzi R, Schmidt H, Huth M, Mildner A, Schmidt-Supprian M, Lassmann H, Prinz MR and Pasparakis M (2006) Inhibition of transcription factor NF-kB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nature Immunology 7 954-961 Van
Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK and Baltimore D (1999) Uncoupling IL-2 signals that regulate T cell proliferation, survival and
Fas-mediated activation-induced cell death. Immunity 11 281-288 Van PL, Yim
KW, Jin DY, Dapolito G, Kurimasa A and Jeang KT (2001) Genetic evidence of a
role for ATM in functional interaction between human T-cell leukemia virus
type 1 Tax and p53. Journal of Virology 75 396-407 van Galen JC, Muris JJ, Giroth CP, Vos W, Ossenkoppele GJ, Meijer CJ and Oudejans JJ (2008) Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas. Histopathology 52 578-584 Van Laere S, Van der Auwere I, Van den Eynden GG, Fox SB, Bianchi F, Harris AL, Van Dam P, Van Marck EA, Vermeulen PB and Dirix LY (2005) Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis. Breast Cancer Research Treatment 93 237-246 Van Luu C, Van Chau M Lee JJ and Jung SH (2006) Exploration of essential structure of malloapelta B for the inhibitory activity against TNF induced NF-kB activation. Archives of Pharmacal Research 29 840-844 van Oers NS and Chen ZJ (2005) Cell biology. Kinasing and clipping down the NF-kB trail. Science 308 65-66 Van
Puijenbroek AA, Wissink S, van der Saag PT and Peppelenbosch MP (1999)
Phospholipase A2 inhibitors and leukotriene synthesis inhibitors block
TNF-induced NF-kB activation. Cytokine 11 104-110 Van Putten V, Refaat Z, Dessev C, Blaine S, Wick M, Butterfield L, Han SY, Heasley LE and Nemenoff RA (2001) Induction of cytosolic phospholipase A2 by oncogenic Ras is mediated through the JNK and ERK pathways in rat epithelial cells. Journal of Biological Chemistry 276 1226-1232 van Uden P, Kenneth NS and Rocha S (2008) Regulation of hypoxia inducible factor-1alpha by NF-kB. Biochemical Journal in press van Vliet C, Bukczynska PE, Puryer MA, Sadek CM, Shields BJ, Tremblay ML and Tiganis T (2005) Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase. Nature Immunology 6 253-260 Van Waes C (2007) Nuclear factor-kB in development, prevention, and therapy of cancer. Clinical Cancer Research 13 1076-1082 Van
Waes C, Chang AA, Lebowitz PF, Druzgal CH, Chen Z, Elsayed YA, Sunwoo JB, Rudy
SF, Morris JC, Mitchell JB, Camphausen K, Gius D, Adams J, Sausville EA and
Conley BA (2005) Inhibition of nuclear factor-kappaB and target genes during
combined therapy with proteasome inhibitor bortezomib and reirradiation in
patients with recurrent head-and-neck squamous cell carcinoma. Int
J Radiat Oncol Biol Phys 63 1400-1412 Vancurova I,
Bellani P and Davidson D (2001) Activation of nuclear factor-kB and its
suppression by dexamethasone in polymorphonuclear leukocytes: newborn versus
adult. Pediatric Research 49 257-262 Vancurova
I, Wu R, Miskolci V and Sun Shishinn (2002) Increased p50/p50 NF-kB
activation in human pappilomavirus type-6- or type-11-induced laryngeal
papilloma tissue. Journal of Virology 76 1533-1536 Vanden Berghe T, Kalai M, Denecker G, Meeus A, Saelens X and Vandenabeele P (2005) Necrosis is associated with IL-6 production but apoptosis is not. Cell Signaling in press Vanden
Berghe T, Kalai M, Van Loo G, Declercq W and Vandenabeele P (2003) Disruption
of HSP90 function reverts TNF-induced necrosis to apoptosis. Journal of
Biological Chemistry 278 5622-5629 Vanden Berghe W, Dijsselbloem N, Vermeulen L, Ndlovu N, Boone E and Haegeman G (2006) Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-kB gene expression by soy isoflavones does not require estrogenic activity. Cancer Research 66 4852-4862 Vanden Berghe W, Francesconi E, De Bosscher K, Resche-Rigon M and Haegeman G (1999) Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kB-dependent mechanism. Molecular Pharmacology 56 797-806 Vanden Berghe W, Ndlovu MN, Hoya-Arias R, Dijsselbloem N, Gerlo S and Haegeman G (2006) Keeping up NF-kB appearances: epigenetic control of immunity or inflammation-triggered epigenetics. Biochemical Pharmacology in press Vanden Berghe W, Plaisance S,
Boone E, De Bosscher K, Schmitz ML, Fiers W and Haegeman G (1998) p38 and
extracellular signal-regulated kinase mitogen-activated protein kinase
pathways are required for nuclear factor-kB p65 transactivation mediated by
tumor necrosis factor. Journal of Biological Chemistry 273 3285-3290
Vandenbroeck K, Alloza I, Gadina M and Matthys P (2004) Inhibiting cytokines
of the interleukin-12 family: recent advances and novel challenges. J Pharm
Pharmacol 56 145-160
Vandermeeren
M, Janssens S, Wouters H, Borghmans I, Borgers M, Beyaert R and Geysen J
(2001) Dimethylfumarate is an inhibitor of cytokine-induced nuclear
translocation of NF-kB1, but not RelA in normal human dermal fibroblast
cells. Journal of Investigative Dermatology 116 124-130 Vandermoere F, El Yazidi-Belkoura I, Demont Y, Slomianny C, Antol J, Lemoine J and Hondermarck H (2006) Proteomic exploration reveals that actin is a signaling target of the kinase akt. Molecular & Cellular Proteomics in press Vanderpool C, Yan F and Polk DB (2008) Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflammatory Bowel Disease in press Vandoros GP, Konstantinopoulos PA, Sotiropoulou-Bonikou G, Kominea A, Papchristou GI, Karamouzis MV, Gkermpesi M, Varakis I and Papavassiliou AG (2005) PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas. Journal of Cancer Research and Clinical Oncology 8 1-9 Vandromme M,
Gauthier-Rouvière C, Lamb N and Fernandez A (1996) Regulation of
transcription factor localization: fine-tuning of gene expression. Trends in
Biochemical Sciences 21 59-64
Vanlandschoot P, Roobrouck A, Van Houtte F and
Leroux-Roels G (2002) Recombinant HBsAg, an apoptotic-like lipoprotein,
interferes with the LPS-induced activation of ERK-1/2 and JNK-1/2 in
monocytes. Biochemical and Biophysical Research Communications 297 486 Vannini N, Lorusso G, Cammarota R, Barberis M, Noonan DM, SPorn MB and Albini A (2007) The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent. Molecular Cancer Therapeutics in press Vannucchi S, Chiantore MV, Fiorucci G, Percario ZA, Leone S, Affabris E and
Romeo G (2005) TRAIL is a key target in S-phase slowing-dependent apoptosis
induced by interferon-beta in cervical carcinoma cells. Oncogene 24 2536-2546 Van't Land B,
Blijlevens NM, Marteijn J, Timal S, Donnelly JP, De Witte TJ and M'Rabet L
(2003) Role of curcumin and the inhibition of NF-kB in the onset of
chemotherapy-induced mucosal barrier injury. Leukemia 18 276-284 Vaquero E, Gukovsky I, Zaninovic V, Gukovskaya AS and Pandol SJ (2001) Localized pancreatic NF-kappaB activation and inflammatory response in taurocholate-induced pancreatitis. Am J Physiol Gastrointest Liver Physiology 280 G1197-G1208 Varela LM, Stangle-Castor NC, Shoemaker SF, Shea-Eaton WK and Ip MM (2001) TNFalpha induces NFkB/p50 in association with the growth and morphogenesis of normal and transformed rat mammary epithelial cells. Journal of Cellular Physiology 188 120-131 Varfolomeev
EE and Ashkenazi A (2004) Tumor necrosis factor: an apoptosis JuNKie? Cell 116
491-497 Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, Zobel K, Dynek JN, Elliott LO, Wallweber HJ, Flygare JA, Fairbrother WJ, Deshayes K, Dixit VM and Vucic D (2007) IAP antagonists induce autoubiquitination of c-IAPs, NF-kB activation, and TNFa-dependent apoptosis. Cell 131 669-681 Varfolomeev E and Vucic D (2008) (Un)expected roles of c-IAPs in apoptotic and NFkB signaling pathways. Cell Cycle 7 in press Varfolomeev E, Wayson SM, Dixit VM, Fiarbrother WJ and Vucic D (2006) The inhibitor of apoptosis protein fusion c-IAP2/MALT1 stimulates NF-kB activation independently of TRAF1 and TRAF2. Journal of Biological Chemistry 281 29022-29029 Varga
AE, Leonardos L, Jackson P, Marreiros A and Cowled PA (2004) Methylation of a
CpG island within the uroplakin Ib promoter: a possible mechanism for loss of
uroplakin Ib expression in bladder carcinoma. Neoplasia 6 128-135 Varghese
J, Chattopadhaya S and Sarin A (2001) Inhibition of p38 kinase reveals a
TNF-a-mediated, caspase- dependent, apoptotic death pathway in a human
myelomonocyte cell line. Journal of Immunology 166 6570-6577 Varin A, Manna SK, Quivy V, Decrion AZ, Van Lint C, Herbein G and Aggarwal BB (2003) Exogenous Nef protein activates NF-kB, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells. Role in AIDS pathogenesis. Journal of Biological Chemistry 278 2219-2227 Varney ML, Olsen KJ, Mosley RL, Bucana CD, Talmadge JE and Singh RK (2002) Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis. In Vivo 16 471-477 Varon C, Duriez A, Lehours P, Menard A, Laye S, Zerbib F, Megraud F and Laharie D (2008) Study of Helicobacter pullorum proinflammatory properties on human epithelial cells in vitro. Gut in press Varro A, Noble PJ, Pritchard DM, Kennedy S, Hart CA, Dimaline R and Dockray GJ (2004) Helicobacter pylori induces plasminogen activator inhibitor 2 in gastric epithelial cells through nuclear factor-kB and RhoA: implications for invasion and apoptosis. Cancer Research 64 1695-702
Varsani H, Patel A, Van Kooyk Y, Woo P and Wedderburn LR (2003) Synovial
dendritic cells in juvenile idiopathic arthritis (JIA) express receptor
activator of NF-kB (RANK). Rheumatology 42 583-590 Varley CL, Armitage S, Hassanshahiraviz G and Dickson AJ (2003) Regulation of the C-X-C chemokine, mob-1, gene expression in primary rat hepatocytes. Cytokine 23 64-75 Vasarhelyi B, Cseh A, Kocsis I, Treszl A, Gyorffy B and Rigo Jr J (2006) Three mechanisms in the pathogenesis of pre-eclampsia suggested by over-represented transcription factor-binding sites detected with comparative promoter analysis. Molecular Human Reproduction 12 31-34 Vaschetto R, Grinstein J, Del Sorbo L, Khine AA, Voglis S, Tullis E, Slutsky AS and Zhang H (2007) Role of human neutrophil peptides in the initial interaction between lung epithelial cells and CD4+ lymphocytes. Journal of Leukocyte Biology in press Vasilaki A, McArdle F, Iwanejko LM and McArdle A (2006) Adaptive responses of mouse skeletal muscle to contractile activity: The effect of age. Mechanisms of Ageing and Development in press Vashisht Gopal YN, Arora TS and Van Dyke MW (2005) Tumour necrosis factor-a depletes histone deacetylase 1 protein through IKK2. EMBO Reports 7 291-296 Vasilev
N, Momekov G, Zaharieva M, Konstantinov S, Bremner P, Heinrich M and Ionkova I
(2005) Cytotoxic activity of a podophyllotoxin-like lignan from Linum tauricum
Willd. Neoplasma 52 425-429 Vasto S, Mocchegiani E, Malavolta M, Cuppari I, Listi F, Nuzzo D, Ditta V, Candore G and Caruso C (2007) Zinc and inflammatory/immune response in aging. Annals of the New York Academy of Sciences 1100 111-122
Vasudevan KM, Gurumurthy S and Rangnekar VM (2004) Suppression of PTEN
expression by NF-kB prevents apoptosis. Molecular and Cellular Biology 24
1007-1021
Vavricka SR, Musch MW, Chang JE, Nakagawa Y, Phanvijhitsiri K, Waypa TS,
Merlin D, Schneewind O and Chang EB (2004) hPepT1 transports muramyl dipeptide,
activating NF-kB and stimulating IL-8 secretion in human colonic Caco2/bbe
cells. Gastroenterology 127 1401-1409
Veckman V, Osterlund P, Fagerlund R, Melen K, Matikainen S and Julkunen I
(2005) TNF-a and IFN-a enhance influenza-A-virus-induced chemokine gene
expression in human A549 lung epithelial cells. Virology 345 96-104 Vega D, Maalouf NM and Sakhaee K (2007) The role of RANK/RANKL/OPG: clinical implications. Journal of Clinical Endocrinology and Metabolism in press Vega F and Medeiros LJ (2001) Marginal-zone B-cell lymphoma of
extranodal mucosa-associated lymphoid tissue type: molecular genetics
provides new insights into pathogenesis. Adv Anat Pathol 8 313-326
Vega MI, Jazirehi AR, Huerta-Yepez S and Bonavida B (2005) Rituximab-induced
inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell
line via inhibition of NF-kB activity: role of YY1 and Bcl-xL in Fas
resistance and chemoresistance, respectively. Journal
of Immunology 175 2174-2183 Vegeler RC, Yip-Schneider MT, Ralstin M, Wu H, Crooks PA, Neelakantan S, Nakshatri H, Sweeney CJ and Schmidt CM (2007) Effect of celecoxib and novel agent LC-1 in a hamster model of lung cancer. Journal of Surgical Research 143 169-176
Veiby OP and Read MA (2004) Chemoresistance: impact of Nuclear Factor (NF)-kB
inhibition by small interfering RNA: commentary re J. Guo et al., enhanced
chemosensitivity to irinotecan by RNA interference-mediated down-regulation of
the NF-kB p65 subunit. Clinical Cancer Research 10 3333-3341 Velez-Pardo C and De Rio MJ (2006) Avoidance of Abeta[(25-35)]/H2O2-induced apoptosis in lymphocytes by the cannabinoid agonists CP55,940 and JWH-015 via receptor-independent and PI3K-dependent mechanisms: role of NF-kB and p53. Medicinal Chemistry 2 471-479 Velez-Pardo C, Morales AT, Rio MJ and Olivera-Angel M (2007) Endogenously generated hydrogen peroxide induces apoptosis via mitochondrial damage independent of NF-kB and p53 activation in bovine embryos. Theriogenology in press
Velez-Pardo C, Ospina GG and Jimenez del Rio M (2002)
Abeta[25-35] peptide and iron promote apoptosis in lymphocytes by an oxidative
stress mechanism: involvement of H2O2, caspase-3, NF-kB, p53 and c-Jun.
Neurotoxicology 23 351-365 Vellaichamy E, Khurana ML, Fink J and Pandey KN (2005) Involvement of the NF-kB/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor-A. Journal of Biological Chemistry 280 19230-19242
Vellaichamy E, Sommana NK and Pandey KN (2005) Reduced cGMP signaling
activates NF-kB in hypertrophied hearts of mice lacking natriuretic peptide
receptor-A. Biochemical and Biophysical Research Communications 327 106-111 Vender JR, Laird MD and Dhadapani KM (2008) Inhibition of NFkB reduces cellular viability in GH3 pituitary adenoma cells. Neurosurgery 62 1122-1127
Vendetti S, Riccomi A, Sacchi A, Gatta L, Pioli C and De Magistris MT (2002)
Cyclic adenosine 5'-monophosphate and calcium induce CD152 (CTLA-4)
up-regulation in resting CD4(+) T lymphocytes. Journal of Immunology 169
6231-6235 Vendrell JA, Ghayad S, Ben-Larbi S, Dumontet C, Mechti N and Cohen PA (2007) A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells. Oncogene 26 4656-4667 Venihaki M, Zhao J and Karalis KP (2003) Corticotropin-releasing hormone deficiency results in impaired splenocyte response to lipopolysaccharide. Journal of Neuroimmunology 141 3-9 Venkatachari NJ, Majumder B and Ayyavoo V (2007) Human immunodeficiency virus (HIV) type 1 Vpr induces differential regulation of T cell costimulatory molecules: direct effect of Vpr on T cell activation and immune function. Virology 358 347-356
Venkatraman A, Ramakrishna B, Shaji R, Nanda Kumar N, Pulimood A and Patra S
(2003) Amelioration of dextran sulphate colitis by butyrate; role of heat
shock protein 70 and nuclear factor kB. American Journal of Physiology: Gastrointestinal Liver
Physiology 285 G177-G184 Venkataraman
L, Burakoff SJ and Sen R (1995) FK506 inhibits antigen receptor-mediated
induction of c-rel in B and T
lymphoid cells. Journal of Experimental Medicine 181 1091-1099 Venkataraman L, Wang W and Sen R (1996) Differential regulation of c-Rel translocation in activated B and T cells. Journal of Immunology 157 1149-1155 Venkatraman
M, Anto RJ, Nair A, Varghese M and Karunagaran D (2005) Biological and
chemical inhibitors of NF-kB sensitize SiHa cells to cisplatin-induced
apoptosis. Molecular Carcinogenesis
44 51-59 Venzi I, Cucinotta M, Caristi S, Mancuso G and Teti D (2007) Transcriptional regulation of IL-8 by Staphylococcus aureus in human conjunctival cells involves activation of AP-1. Investigative Ophthalmology & Vision Science 48 270-276 Verbrugge I, de Vries E, Tait SW, Wissink EH, Walczak H, Verheij M and Borst J (2008) Ionizing radiation modulates the TRAIL death-inducing signaling complex, allowing bypass of the mitochondrial apoptosis pathway. Oncogene 27 574-584 Vercammen D,
Brouckaert G, Denecker G, Van de Craen M, Declercq W, Fiers W and
Vandenabeele P (1998) Dual signaling of the Fas receptor: initiation of both
apoptotic and necrotic cell death pathways. Journal of Experimental Medicine
188 919-930 Vercammen E, Staal J, Van Den Broeke A, Haegman M, Vereecke L, Schotte P and Beyaert R (2008) Prolonged exposure to IL-1b and IFNg induces necrosis of L929 tumor cells via a p38MAPK/NF-kB/NO-dependent mechanism. Oncogene 27 3780-3788 Veres B, Radnai B, Gallyas F, Varbiro G, Berente Z, Osz E and Sumegi B (2004) Regulation of kinase cascades and transcription factors by a poly-(ADP-Ribose) polymerase-1 inhibitor - 4-hydroxyquinazoline - in LPS-induced inflammation in mice. Journal of Pharmacology and Experimental Therapeutics 310 247-255 Verhaeghe C, Remouchamps C, Hennuy B, Vanderplasschen A, Chariot A, Tabruyn SP, Oury C adn Bours V (2007) Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways. Biochemical Pharmacology 73 1982-1994 Verhasselt V,
Vanden Berghe W, Vanderheyde N, Willems F, Haegeman G and Goldman M (1999)
N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic
cell level: association with NF-kB inhibition. Journal of Immunology 162
2569-2574 Verhoef K, Sanders RW, Fontaine V, Kitajima S and Berkhout B (1999) Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kB enhancer element into a GABP binding site. Journal of Virology 73 1331-1340 Verkoczy L, Ait-Azzouzene D, Skog P, Martensson A, Lang J, Duong B and Nemazee D (2005) A role for nuclear factor kB/rel transcription factors in the regulation of the recombinase activator genes. Immunity 322 519-531 Verma A and Mehta K (2007) Tissue transglutaminase-mediated chemoresistance in cancer cells. Drug Resistance Updates 10 144-151 Verma A and Mehta K (2007) Transglutaminase-mediated activation of nuclear transcription factor-kB in cancer cells: a new therapeutic opportunity. Current Cancer Drug Targets 7 559-565 Verma IM and
Stevenson J (1997) IkB kinase: beginning, not the end. Proceedings of the
National Academy of Sciences USA 94 11758-11760 Verma IM and
Vogt P (1995) Oncogenes: 20 years later. Genes & Development 9 1289-1301 Verma IM,
Stevenson JK, Schwarz EM, Van Antwerp D and Miyamato S (1995) Rel/NF-kB/IkB
family: intimate tales of association and disassociation. Genes & Development 9 2723-2735 Verma UN, Yamamoto Y, Prajapati S and Gaynor RB (2004) Nuclear role of IKKg/NEMO
in NF-kB-dependent gene expression. Journal of Biological Chemistry 279
3509-3515 Vermeulen L, De Wilde G, Damme PV, Vanden Berghe W and Haegeman G (2003)Transcriptional
activation of the NF-kB p65 subunit by mitogen- and stress-activated protein
kinase-1 (MSK1). EMBO Journal 22 1313-1324 Vermeulen L, Vanden Berghe W and Haegeman G (2006) Regulation of NF-kB transcriptional activity. Cancer Treatment and Research 130 89-102 Verna L, Ganda C and Stemerman MB (2006) In vivo low-density lipoprotein exposure induces intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 correlated with activator protein-1 expression. Arteriosclerosis, Thrombosis and Vascular Biology 26 1344-1349 Vernal R, Chaparro A, Graumann R, Puente J, Valenzuela MA and Gamonal J (2004) Levels of cytokine receptor activator of nuclear factor kB ligand in gingival crevicular fluid in untreated chronic periodontitis patients. Journal of Periodontology 75 1586-1591 Vernon DO, Garbuzova-Davis S, Desjarlais T, Singh Rasile R, Sanberg PR, Willing AE and Pennypacker KR (2006) Reduced Nuclear Factor kB activation in dentate gyrus after active avoidance training. Brain Research 1104 39-44 Verrax J, Cadrobbi J, Delvaux M, Jamison JM, Gilloteaux J, Summers JL, Taper
HS and Buc Calderon P (2003) The association of vitamins C and K(3) kills
cancer cells mainly by autoschizis, a novel form of cell death. Basis for
their potential use as coadjuvants in anticancer therapy. European Journal of
Medicinal Chemistry 38 451-457
Verrecchia F, Wagner EF and
Mauviel A (2002) Distinct involvement of the Jun-N-terminal kinase and NF-kB
pathways in the repression of the human COL1A2 gene by TNF-alpha. EMBO Reports
3 1069-1074 Verstrepen L, Adib-Conquy M, Kreike M, Carpentier I, Adrie C, Cavaillon JM and Beyaert R (2008) Expression of the NF-kB inhibitor ABIN-3 in response to TNF and Toll-like receptor 4 stimulation is itself regulated by NF-kB. Journal of Cellular and Molecular Medicine 12 316-329 Verstrepen L, Bekaert T, Chau TL, Tavernier J, Chariot A, and Beyaert R (2008) TLR-4, IL-1R and TNF-R signaling to NF-kB: variations on a common theme. Cellular and Molecular Life Sciences in press Verweij
Cl,
Geerts M and Aarden LA (1991) Activation of interleukin-2 gene transcription
via the T-cell surface molecule CD28 is mediated through an NF-kB-like
response element. Journal of Biological Chemistry 266 14179-14182 Verzola D, Bertolotto MB, Villaggio B, Ottonello L, Dallegri F, Salvatore F,
Berruti V, Gandolfo MT, Garibotto G and Deferrari G (2003) Oxidative stress
mediates apoptotic changes induced by hyperglycemia in human tubular kidney
cells. Journal of the American Society of Nephrology 15 S85-S87 Vestergaard C, Johansen C, Otkjaer K, Deleuran
M and Iversen L (2005) Tumor
necrosis factor-a-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine)
production in keratinocytes is controlled by nuclear factor kB. Cytokine 29
49-55 Viatour P,
Bentires-Alj M, Chariot A, Deregowski V, De Leval L, Merville MP and Bours V
(2003) NF-kB2/p100 induces Bcl-2 expression. Leukemia 17 1349-1356 Vickers TA,
Griffith MC, Ramasamy K, Risen LM and Freier SM (1995) Inhibition of NF-kB
specific transcriptional activation by PNA strand invasion. Nucleic Acids
Research 23 3003-3008 Victor FC, Gottlieb AB and Menter A (2003) Changing paradigms in dermatology: tumor necrosis factor alpha (tnf-alpha) blockade in psoriasis and psoriatic arthritis. Clinical Dermatology 21 392-397 Victor VM and De
la Fuente M (2002) N-acetylcysteine improves in vitro the function of
macrophages from mice with endotoxin-induced oxidative stress. Free Radical
Research
36 33-45 Victor VM, Rocha M and De la Fuente M (2003) N-acetylcysteine protects mice
from lethal endotoxemia by regulating the redox state of immune cells. Free
Radical Research 37 919-929 Victoriano AF, Asamitsu K, Hibi Y, Imai K, Barzaga NG and Okamoto T (2006) Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkB kinase inhibitor. Antimicrobioal Agents and Chemotherapy 50 547-555 Vidaeff AC, Ramin SM, Gilstrap 3rd LC, Bishop KD and Alcorn JL (2007) Impact of progesterone on cytokine-stimulated nuclear factor-kB signaling in HeLa cells. Journal of Maternal- Fetal Neonatal Medicine 2007 Jan;20(1):23-8 Vidal C, Gomez-Hernandez A, Sanchez-Galan E, Gonzalez A, Ortega L, Gomez-Gerique JA, Tunon J and Egido J (2006) Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis. Journal of Pharmacology and Experimental Therapeutics 320 108-116 Vidal MA, Astroza A, Matus CE, Ehrenfeld P, Pavicic F, Sanchez T, Salem C,
Figueroa J, Concha M, Gonzalez CB and Figueroa CD (2005) Kinin b2
receptor-coupled signal transduction in human cultured keratinocytes. Journal
of Investigative Dermatology 124 178-186 Videla LA,
Fernandez V, Tapia G and Varela P (2003) Oxidative stress-mediated
hepatotoxicity of iron and copper: role of Kupffer cells. Biometals 16 103-111 Viedt
C, Shen W, Fei J, Kamimura M, Hansch GM, Katus HA and Kreuzer J (2003) HMG-CoA
reductase inhibition reduces the proinflammatory activation of human vascular
smooth muscle cells by the terminal complement factor C5b-9. Basic Research in
Cardiology
98 353-361 Vier J, Gerhard M, Wagner H and Hacker G (2004) Enhancement of death-receptor
induced caspase-8-activation in the death-inducing signalling complex by
uncoupling of oxidative phosphorylation. Molecular Immunology 40 661-670 Vig E, Green
M, Liu Y, Donner DB, Mukaida N, Goebl MG and Harrington MA (1999) Modulation
of tumor necrosis factor and interleukin-1-dependent NF-kB activity by
mPLK/IRAK. Journal of Biological Chemistry 274 13077-13084
Vignola AM, Chiappara G, Siena L, Bruno A, Gagliardo
R, Merendino AM, Polla BS, Arrigo AP, Bonsignore G, Bousquet J and Chanez P
(2001) Proliferation and activation of bronchial epithelial cells in corticosteroid-dependent asthma. Journal
of Allergy and Clinical Immunology 108 738-746 Vila-Del Sol V and Fresno M (2005) Involvement of TNF and NF-kB in the transcriptional control of cyclooxygenase-2 expression by IFN-gamma in macrophages. Journal of Immunology 174 2825-2833 Vilar M, Murillo-Carretero M, Mira H, Magnusson K, Besset V and Ibanez CF (2006) Bex1, a novel interactor of the p75 neurotrophin receptor, links neurotrophin signaling to the cell cycle. EMBO Journal 25 1219-1230 Vilela RM, Lands LC, Meehan B and Kubow S (2006) Inhibition of IL-8 release from CFTR-deficient lung epithelial cells following pre-treatment with fenretinide. International Immunopharmacology 6 1651-1664 Vilimas T, Mascarenhas J, Palomero T, Mandal M, Buonamici S, Meng F, Thompson B, Spaulding C, Macaroun S, Alegre ML, Kee BL, Ferrando A, Miele L and Aifantis I (2007) Targeting the NF-kB signaling pathway in Notch1-induced T-cell leukemia. Nature Medicine 13 70-77 Villalba M and
Altman A (2002) Protein Kinase C-theta (PKCtheta), a potential drug target for
therapeutic intervention with human T cell leukemias. Current Cancer Drug Targets
2 125-137 Villalba
M, Bushway P and Altman A (2001) Protein kinase C-theta mediates a selective
T cell survival signal via phosphorylation of BAD. Journal of Immunology 166
5955-5963 Villalona-Calero M, Schaaf L, Phillips G, Otterson G, Panico K, Duan W, Kleiber B, Shah M, Yong D, Wu WH and Kuhn J (2007) Thalidomide and celecoxib as potential modulators of irinotecan's activity in cancer patients. Cancer Chemotherapy and Pharmacology 59 23-33 Villar J, Celay J, Alonso MM, Rotinen M, de Miguel C, Migliaccio M and Encio I (2007) Transcriptional regulation of the human type 8 17beta-hydroxysteroid dehydrogenase gene by C/EBPbeta. Journal of Steroid Biochemistry and Molecular Biology 105 131-139 Villunger A,
Ghaffari-Tabrizi N, Tinhofer I, Krumbock N, Bauer B, Schneider T, Kasibhatla
S, Greil R, Baier-Bitterlich G, Uberall F, Green DR and Baier G (1999)
Synergistic action of protein kinase C theta and calcineurin is sufficient
for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway
in Jurkat T cells. European Journal of Immunology 29 3549-3561 Vinayagamoorthi R, Koner BC, Kavitha S, Nandakumar DN, Padma Priya P and Goswami K (2005) Potentiation of humoral immune response and activation of NF-kB pathway in lymphocytes in experimentally induced hyperthyroid rats. Cellular Immunology 238 56-60 Vince JE, Chau D, Callus B, Wong WW, Hawkins CJ, Schneider P, McKinlay M, Benetatos CA, Condon SM, Chunduru SK, Yeoh G, Brink R, Vaux DL and Silke J (2008) TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFa. Journal of Cell Biology in press Vince JE, Wong WW, Khan N, Feltham R, Chau D, Ahmed AU, Benetatos CA, Chunduru SK, Condon SM, McKinlay M, Brink R, Leverkus M, Tergaonkar V, Schneider P, Callus BA, Koentgen F, Vaux DL and Silke J (2007) IAP antagonists target cIAP1 to induce TNFa-dependent apoptosis. Cell 131 682-693 Vincenti MP, Burrell TA and Taffet SM (1992) Regulation of NF-kB activity in murine
macrophages: effect of bacterial lipopolysaccharide and phorbol ester. Journal of Cellular Physiology 150 204-213 Vines A, Cahoon S, Goldberg I, Saxena U and Pillaarisetti S (2006) Novel anti-inflammatory role for glycogen synthase kinase-3beta in the inhibition of tumor necrosis factor-a- and interleukin-1b-induced inflammatory gene expression. Journlal of Biological Chemistry 281 16985-16990 Vink A, Schoneveld AH, van der Meer JJ, van Middelaar
BJ, Sluijter JP, Smeets MB, Quax PH, Lim SK, Borst C, Pasterkamp G and de
Kleijn DP (2002) In vivo evidence for a role of toll-like receptor 4 in the
development of intimal lesions. Circulation 106 1985-1990 Vincenti MP,
Coon CI and Brinckerhoff CE (1998) Nuclear factor kB/p50 activates an element
in the distal matrix metalloproteinase 1 promoter in interleukin-1b-stimulated synovial fibroblasts. Arthritis and Rheumatism 41
1987-1994 Vinolo E, Sebban H, Chaffotte A, Israel A, Courtois G, Veron M and Agou F (2006) A point mutation in NEMO associated with EDA-ID pathology results in destabilisation of the oligomer and reduces LPS- and TNF-mediated NF-kB activation. Journal of Biological Chemistry 281 6334-6348 Virag L (2005) Poly(ADP-ribosyl)ation in asthma and other lung diseases. Pharmacology Research 52 83-92 Virag
L (2005) Structure and function of poly(ADP-ribose) polymerase-1: role in
oxidative stress-related pathologies. Current Vascular Pharmacology 3 209-214 Virlos I, Mazzon E, Serraino I, Genovese T, Di Paola R, Thiemerman C, Siriwardena A and Cuzzocrea S (2004) Calpain I inhibitor ameliorates the indices of disease severity in a murine model of cerulein-induced acute pancreatitis. Intensive Care Med 30 1645-1651 Visconti R,
Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K, Miano MP, de Nigris F,
Casalino L, Curcio F, Santoro M and Fusco A (1997) Expression of the
neoplastic phenotype by human thyroid carcinoma cell lines requires NFkB p65
protein expression. Oncogene 15 1987-1994 Visekruna A, Joeris T, Seidel D, Kroesen A, Loddenkemper C, Zeita M, Kaufmann SH, Schmidt-Ullrich R and Steinhoff U (2006) Proteasome-mediated degradation of IkBa and processing of p105 in Crohn disease and ulcerative colitis. Journal of Clinical Investigation 116 3195-3203 Visentin S, Renzi
M and Levi G (2001) Altered outward-rectifying K(+) current reveals
microglial activation induced by HIV-1 Tat protein. Glia 33 181-190 Visvanathan
KV and Goodbourn S (1989) Double-stranded RNA activates binding of NF-kB to
an inducible element in human beta-interferon promoter. EMBO Journal 8 1129-1138 Visvanathan M, Breit M, Pfeifer B, Baumgartner C, Modre-Osprian R, and Tilg B (2007) Systematic analysis of signaling pathways using an integrative environment. Methods of Information in Medicine 46 386-391 Viswanathan
M, Yu M, Mendoza L and Yunis JJ (1996) Cloning and transcription
factor-binding sites of the human c-rel proto-oncogene promoter. Gene 170
271-276 Viterbo D, Bluth MH, Mueller CM and Zenilman ME (2008) Mutational characterization of pancreatitis-associated protein 2 domains involved in mediating cytokine secretion in macrophages and the NF-kB pathway. Journal of Immunology 181 1948-1958 Vitiello M, D'Isanto M, Galdiero M, Raieta K, Tortora A, Rotondo P, Peluso L
and Galdiero M (2004) Interleukin-8 production by THP-1 cells stimulated by
Salmonella enterica serovar Typhimurium porins is mediated by AP-1, NF-kB and
MAPK pathways. Cytokine 27 15-24 Vitseva OL, Tanriverdi K, Tchkonia TT, Kirkland JL, McDOnnell ME, APovian CM, Freedman J and Gokce N (2008) Inducible Toll-like receptor and NF-kB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) in press Vitturo E, Farke C, Meyer HH and Albrecht C (2006) Identification, sequence analysis and mRNA tissue distribution of the bovine sterol transporters ABCG5 and ABCG8. Journal of Dairy Science 89 553-561 Vlach J and
Pitha PM (1992) Activation of human immunodeficiency virus type 1 provirus in
T-cells and macrophages is associated with induction of inducer-specific
NF-kB binding proteins. Virology 187 63-72 Vlach J and
Pitha PM (1992) Herpes simplex virus type 1-mediated induction of human
immunodeficiency viurs type 1 provirus correlates with binding of nuclear
proteins to the NF-kB enahncer and leader sequence. Journal of Virology 66
3616-3623 Vlach J,
Garcia A, Jacqué J-M, Rodriguez MS, Michelson S and Virelizier J-L (1995)
Induction of Sp1 phosphorylation and NF-kB-independent HIV promoter domain
activity in T lymphocytes stimulated by okadaic acid. Virology 208 753-761 Vlaeminck-Guillem
V, Laudet V and Duterque-Coquillaud M (2003) Negative cross-talk between
nuclear receptors and transcription factors: implications in inflammation and
oncogenesis [Article in French]. Med Sci (Paris) 19 1121-1127 Voboril R, Hochwald SN, Li J, Brank A, Weberova J, Wessels F, Moldawer LL, Ramsay Camp E and MacKay SL (2004) Inhibition of NF-kB augments sensitivity to 5-Fluorouracil/Folinic acid in colon cancer(1). Journal of Surgical Research 120 178-188 Voboril R, Voborliova J, Rychterova V, Jrasek T and Dvorak J (2008) Dissociated invasively growing cancer cells with NF-kB/p65 positivity after radiotherapy: a new marker for worse clinical outcome in rectal cancer? Preliminary data. Clinical and Experimental Metastasis in press Voboril R, Weberova J and Dvorak J (2005) The molecular screening of the stool for the colorectal carcinoma [Article in Czech]. Rozhl Chir 84 281-285 Voboril R and Weberova-Voborilova J (2006) Constitutive NF-kB activity in colorectal cancer cells: impact on radiation-induced NF-kB activity, radiosensitivity, and apoptosis. Neoplasma 53 518-523 Voboril R and Weberova-Voborilova J (2007) Sensitization of colorectal cancer cells to irradiation by IL-4 and IL-10 is associated with inhibition of NF-kB. Neoplasma 54 495-502 Voboril R, Weberova-Voborilova J, Rychterova V, Ambrus M, Horak L and Fanta J (2007) NF-kB, colorectal carcinoma and radiotherapy: results of a clinical and experimental study [Article in Czech]. Rozhledy v Chirurgii 86 268-272 Vockerodt
M,
Haier B, Buttgereit P, Tesch H and Kube D (2001) The Epstein-Barr virus
latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells
but not in Hodgkin's cells involving the p38/SAPK2 pathway. Virology 280
183-198 Voelter-Mahlknecht S and Mahlknecht U (2006) Cloning, chromosomal characterization and mapping of the NAD-dependent histone deacetylases gene sirtuin 1. International Journal of Molcular Medicine 17 59-67 Vogel CF, Sciullo E, Li W, Wong P, Lazennec G and Matsumura F (2007) RELB, a new partner of aryl hydrocarbon receptor-medicated transcription. Molecular Endocrinology 21 2941-2955
Vogel CF, Sciullo E and Matsumura F (2007)
Involvement of RelB in aryl hydrocarbon receptor-mediated induction of
chemokines.
Vogel CF, Zhao Y, Wong P, Young NF and Matsumura F (2003) The use of c-src
knockout mice for the identification of the main toxic signaling pathway of
TCDD to Induce wasting syndrome. Journal of Biochemical and Molecular
Toxicology 17 305-315 Vogel NL, Boeke M and Ashburner BP (2006) Spermidine/Spermine N(1)-Acetyltransferase 2 (SSAT2) functions as a coactivator for NF-kB and cooperates with CBP and P/CAF to enhance NF-kB-dependent transcription. Biochimica et Biophysica Acta 1759 470-477 Vogel S, Orrington-Myers J, Broman M and Malik AB (2006) De novo ICAM-1 synthesis in the mouse lung: model of assessment of protein expression in lungs. American Journal of Physiology: Lung Cell and Molecular Physiology 291 L496-L501 Vogel
SN,
Johnson D, Perera PY, Medvedev A, Lariviere L, Qureshi ST and Malo D (1999)
Functional characterization of the effect of the C3H/HeJ defect
in mice that lack an Lpsn gene: in vivo evidence for a dominant negative
mutation. Journal of Immunology 162 5666-5670 Vogel U, Nexo BA, Tjonneland A, Wallin H, Hertel O and Raaschou-Nielsen O (2006) ERCC1, XPD and RAI mRNA levels in lymphocytes are not associated with lung cancer risk in a prospective study of Danes. Mutation Research 593 88-96 Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll, Sorg C and Roth J (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nature Medicine 13 1042-1049 Vogt PK
(2001) Jun, the oncoprotein. Oncogene 20 2365-2377 Voisard
R, Huber N, Baur R, Susa M, Ickrath O, Both A, Koenig W and Hombach V (2001)
Different effects of antisense RelA p65 and NF-kappaB1 p50 oligonucleotides on
the nuclear factor-kappaB mediated expression of ICAM-1 in human coronary
endothelial and smooth muscle cells. BMC Molecular Biology 2 7 Volger OL, Fledderus JO, Kisters N, Fontijn RD, Moerland PD, Kuiper J, van Berkel TJ, Bijnens AP, Daemen MJ, Pannekoek H and Horrevoets AJ (2007) Distinctive expression of chemokines and transforming growth factor-b Signaling in human arterial endothelium during atherosclerosis. American Journal of Pathology 171 326-337 Volk DE, Yang
X, Fennewald SM, King DJ, Bassett SE, Venkitachalam S, Herzog N,
Luxon BA, Gorenstein DG (2002) Solution structure and design of
dithiophosphate backbone aptamers targeting transcription factor NF-kB.
Bioorganic Chemistry 30 396-419 Vollgraf U, Wegner M and Richter-Landsberg C (1999) Activation of AP-1 and nuclear factor-kB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. Journal of Neurochemistry 73 2501-2509 Volp K, Brezniceanu ML, Bosser S, Brabletz T, Kirchner T, Gottel D, Joos S and Zornig M (2006) Increased expression of High Mobility Group Box 1 (HMGB1) is associated with an elevated level of the anti- apoptotic c-IAP2 protein in human colon carcinomas. Gut 55 234-242 Volpini RA, balbi
AP, Costa RS and Coimbra TM (2006) Increased expression of p38 mitogen-
activated protein kinase is related to the acute renal lesions induced by
gentamicin. Volpini RA, Costa RS, da Silva CG and Coimbra TM (2004) Inhibition of nuclear factor-kB activation attenuates tubulointerstitial nephritis induced by gentamicin. Nephron Physiology 98 97-106 von Albertini
M, Ferran C, Brostjan C, Bach FH and Goodman DJ (1998) Membrane-associated
lymphotoxin on natural killer cells activates endothelial cells via an
NF-kB-dependent pathway. Transplantation 66 1211-1219 von Beust BR, Johansen P, Smith KA, Bot A, Storni T and Kundig TM (2005) Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration. European Journal of Immunology 35 1869-1876 von Bismarck P, Klemm K, Wistadt CF, Winoto-Morbach S, Uhlig U, Schutze S, Uhlig S, Lachmann B and Krause MF (2007) Surfactant "fortification" by topical inhibition of nuclear factor-kB activity in a newborn piglet lavage model. Critical Care Medicine 35 2309-2318 von Brandenstein MG, Ngum Abety A, Depping R, Roth T, Koehler M, Dienes HP and Fries JW (2008) A p38-p65 transcription complex induced by endothelin-1 mediates signal transduction in cancer cells. Biochimica et Biophysica Acta 1783 1613-1622 Von Bubnoff D,
Novak N, Kraft S and Bieber T (2003) The central role of
FcepsilonRI in allergy. Clinical and Experimental Dermatology 28 184-187 von Bulow V, Dubben S, Engelhardt G, Hebel S, Plumakers B, Heine H, Rink L and Haase H (2007) Zinc-dependent suppression of TNF-a production is mediated by protein kinase A-induced inhibition of Raf-1, IkB kinase beta, and NF-kB. Journal of Immunology 179 4180-4186 von Gagern G, Zimmermann T, Albrecht S, Bachmann L, Zwipp H and Saeger HD (1999) [Significance of selenium in regulation of inflammatory response by transcription factors in polytrauma patients. A clinical study]. Med Klin 94 Suppl 3 62-65 von Haehling
S, Genth-Zotz S, Anker S and Volk H (2002) Cachexia: a therapeutic approach
beyond cytokine antagonism. International Journal of Cardiology 85 173-183
von Knethen
A, Callsen D and Brune B (1999) NF-kB and AP-1 activation by nitric oxide
attenuated apoptotic cell death in RAW 264.7 macrophages. Molecular Biology
of the Cell 10 361-372 von Knethen
A, Callsen D and Brune B (1999) Superoxide attenuates macrophage apoptosis by
NF-kB and AP-1 activation that promotes cyclooxygenase-2 expression.
Journal of Immunology 163 2858-2866 von Knethen A, Soller M, Tzieply N, Wiegert A, Johann AM, Jennewein C, Kohl R and Brune B (2007) PPARgamma1 attenuates cytosol to membrane translocation of PKCalpha to desensitize monocytes/macrophages. Journal of Cell Biology 176 681-694 von
Leoprechting A, van der Bruggen P, Pahl HL, Aruffo A and Simon JC (1999)
Stimulation of CD40 on immunogenic human malignant melanomas augments their
cytotoxic T lymphocyte-mediated lysis and induces apoptosis. Cancer Research
59 1287-1294 Von Wnuck Lipinski K, Keul P, Ferri N, Lucke S, Heusch G, Fischer JW and Levkau B (2006) Integrin-mediated transcriptional activation of inhibitor of apoptosis proteins protects smooth muscle cells against apoptosis induced by degraded collagen. Circulation Research 98 1490-1497 Vona-Davis L, Yu A, Magabo K, Evans T, Jackson B, Riggs D and McFadden D
(2004) Peptide YY attenuates transcription factor activity in tumor necrosis
factor-alpha-induced pancreatitis. Journal of the American College of Surgeons
199 87-95 Vos IH, Govers R, Grone HJ, Kleij L, Schurink M, De Weger RA,
Goldschmeding R and Rabelink TJ (2000) NFkB decoy oligodeoxynucleotides
reduce monocyte infiltration in renal allografts. FASEB Journal 14 815-822 Vos TA, Goor
H, Tuyt L, Jager-Krikken A, Leuvenink R, Kuipers F, Jansen PL and Moshage H
(1999) Expression of inducible nitric oxide synthase in endotoxemic rat
hepatocytes is dependent on the cellular glutathione status. Hepatology 29
421-426 Vosters O, Beuneu C, Goldman M and Verhasselt V (2008) N-acetylcysteine derivative inhibits CD40-dependent proinflammatory properties of human pancreatic duct cells. Pancreas 36 363-368 Vosters O, Beuneu C, Nagy N,
Movahedi B, Aksoy E, Salmon I, Pipeleers D,
Goldman M and Verhasselt V (2004) CD40 expression on human pancreatic duct
cells: role in nuclear factor-kB activation and production of pro-inflammatory
cytokines. Diabetologia 47 660-668 Vroling AB, Jonker MJ, Luiten S, Breit TM, Fokkens WJ and van Drunen CM (2008) Primary Nasal epithelium exposed to house dust mite extract shows activated expression in allergics. American Journal of Respiratory Cell and Molecular Biology 38 293-299 Vuillard L, Nicholson J and Hay RT (1999) A complex containing betaTrCP recruits Cdc34 to catalyze ubiquitination of IkBa. FEBS Letters 455 311-314 Vunta H, Davis F, Palempalli UD, Bhat D, Arner RJ, Thompson JT, Peterson DG, Reddy CC and Prabhu KS (2007) The antiinflammatory effects of selenium are mediated through 15-deoxy-u 12,14-prostaglandin J2 in macrophages. Journal of Biological Chemistry 282 17964-17973 Vuolteenaho K, Kujala P, Moilanen T and Moilanen E (2005) Aurothiomalate and hydroxychloroquine inhibit nitric oxide production in chondrocytes and in human osteoarthritic cartilage. Scandinavian Journal of Rheumatology 34 475-479 Vuori KA, Nordlund E, Kallio J, Salakoski T and Nikinimaa M (2008) Tissue-specific expression of aryl hydrocarbon receptor and putative developmental regulatory modules in Baltic salmon yolk-sac fry. Aquatic Toxicology 87 19-27 Vykhovanets EV, Shukla S, Maclennan GT, Resnick MI, Carlsen H, Blomhoff R and Gupta S (2007) Molecular imaging of NF-kB in prostate tissue after systemic administration of IL-1beta. Prostate 68 34-41 Vuolteenaho K,
Moilanen T, Jalonen Y, Lahti A, Nieminen G, Beuningen HM, Kraan PM and
Moilanen E (2005) TGFbeta inhibits IL-1 -induced iNOS expression and NO
production in immortalized chondrocytes. Inflammation Research 54 420-427 |